Movement disorders in dental practice

Improving Oral Health for the Elderly: An Interdisciplinary Approach

Volumn , Issue , 2008, Pages 79-97

  Browner, Nina M ^a   Frucht, Steven ^a  

^a Howard Hughes Medical Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892311858     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-74337-0_5     Document Type: Chapter

References (77)

1. Aarsland, D., Zaccai, J., & Brayne, C. (2005). A systematic review of prevalence studies of dementia in Parkinson's disease. Movement Disorders, 20, 1255-1263.
2. Ackermans, L., Temel, Y., Cath, D., van der Linden, C., Bruggerman, R., Kleijer, M., Nederveen, P., Schruers, K., Colle, H., Tijssen, M.A., Visser-Vandewalle, V., & Dutch Flemish Tourette Surgery Study Group. (2006). Deep brain stimulation in Tourette's syndrome: two targets? Movement Disorders, 21, 709-713.
3. Alexander, R.E., & Gage, T.W. (2000). Parkinson's disease: an update for dentists. General Dentistry, 48, 572-580.
4. Blanchet, P.J., Allard, P., Gregoire, L., Tardif, F., & Bernard, P.J. (1996). Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients. Canadian Journal of Neurological Science, 23, 189-193.
5. Blanchet, P.J., Rompre, P.H., Lavingne, G.J., & Lamarche, C. (2005). Oral dyskinesia: a clinical overview. The International Journal of Prosthodontics, 18, 10-19.
6. Bonifati, V., Rizzi, P., van Baren, M.J., Schaap, O., Breedveld, G.J., Krieger, E., & Dekker, M.C. (2003). Mutation in DJ-1 gene associated with autosomal recessive early - onset parkinsonism. Science, 299, 256-259.
7. Bower, J.H.,Maraganore, D.M.,McDonnell, S.K.,& Rocca,W.A. (1997). Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota 1976-1990. Neurology, 49, 1284-1288.
8. Bower, J.H., Maraganore, D.M., & McDonnell, S.K. (1999). Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology, 52, 1214-1220.
9. Bradford, H., Britto, L.R., Leal, G., & Katz, J. (2004). Endodontic treatment of a patient with Huntington's disease. Journal of Endodontics, 30, 366-369.
10. Bressman, S.B. (2000). Dystonia update. Clinical Neuropharmacology, 23, 239-251.
11. Bressman, S.B., Sabatti, C., Raymond, D., de Leon D, Klein, C., Kramer, P.L., Brin,M.F., Fahn, S., Breakefield, X., Oselius, L.J., & Risch, N.J. (2000). The DYT1 phenotype and guidelines for diagnostic testing. Neurology, 54, 1746-1752.
12. Chakos, M.H., Alvir, J.M.J., Woerner, M.G., Koreen, A., Geisler, S., Mayerhoff, D., Sobel, S., Kane, J.M., Borenstein. M., & Lieberman, J.A. (1996). Incidence and correlates of tardive dyskinesia in first episode of schizophrenia. Archives of General Psychiatry, 53, 313-319.
13. Clifford, T., & Finnerty, J. (1995). The dental awareness and needs of Parkinson's disease population. Gerontology, 12, 99-103.
14. Collins, R. (1990). Special considerations for the dental patient with Parkinson's disease. Texas Dentistry Journal, 107, 31-33.
15. Comings, D.E., Himes, J.A., & Comings, B.G. (1990). An epidemiologic study of Tourette's syndrome in a single school district. Journal of Clinical Psychiatry, 51, 463-469.
16. Deuschl, G., & Elble, R.J. (2000). The pathophysiology of essential tremor. Neurology, 54 (suppl. 4), S14-S20.
17. Dujardin, K., Defbvre, L., & Grunberg, C. (2001). Memory and executive function in sporadic and familial Parkinson's disease. Brain, 123, 115-1160.
18. Fahn, S., Bressman, S.B., & Marsden, C.D. (1998). Classification of dystonia. Advances in Neurology, 78, 1-10.
19. Feeney, A.W. (1985). Dental treatment considerations for patients with Huntington's chorea: a literature review and case report. Journal of Connecticut State Dental Association, 59, 118-123.
20. Findley, L.J. (2000). Epidemiology and genetics of essential tremor. Neurology, 54 (suppl 4), S8-S13.
21. Friedlander, A.H., & Cummings, J.L. (1992). Dental treatment of patients with Gilles de la Tourette's syndrome. Oral Surgery, Oral Medicine and Oral Pathology, 73, 299-303.
22. Frucht, S., Fahn, S., Ford, B., & Gelb, M. (1999). A geste antagoniste device to treat jaw - closing dystonia. Movement Disorders, 14, 883-886.
23. Fukayo, S., Nonaka, K., Shimizu, T., & Yano, E. (2003). Oral health of patient with Parkinson's disease: factors related to their better dental status. Tohoku Journal of Experimental Medicine, 201, 171-179.
24. Geene, P., Kahn, U.J., & Fahn, S. (1995). Spread of symptoms in idiopathic torsion dystonia. Movement Disorders, 10, 143-152.
25. Golbe, L.I., Davis, P.H., Schoenberg, B.S.,& Duvoisin, R.C. (1988). Prevalence and natural history of progressive supranuclear palsy. Neurology, 38, 1031-1034.
26. Greene, P., Shale, H., & Fahn, S. (1988). Experience with high dosages of anticholinergic and other drugs in the treatment of torsion dystonia. Advances in Neurology, 50, 547-556.
27. Jankovic, J. (2004). Dystonia: medical therapy and botulinum toxin. Advances of Neurology, 94, 275-286.
28. Jeste, D.V., &Wyatt, R.J. (1982). Therapeutic strategies against tardive dyskinesia; two decades of experience. Archives of Psychiatry, 39, 803-816.
29. Jost, W.H., & Kohl, A. (2001). Botulinum toxin: evidence-based medicine criteria in rare indications. Journal of Neurology, 248 (suppl 1), 39-44.
30. Kane, J.M., & Smith, J.M. (1982). Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Archives of General Psychiatry, 39, 473-481.
31. Kane, J.M.,Woerner,M., Borenstein,M.,Wegner, J., &Lieberman, J. (1986). Integrating incidence and prevalence of tardive dyskinesia. Psychopharmacology Bulletin, 22, 254-258.
32. Kelleher, M.G.D., Scott, B.J.J., & Djemal, S. (1998). Case report: Complications of rehabilitation using osseointegrated implants - tardive dyskinesia. European Journal of Prosthodontics and Restorative Dentistry, 6, 133-136.
33. Kitada, T., Asakawa, S., Hattori, N., &Yamamura, Y. (1998). Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 392, 605-608.
34. Kokmen, E., Ozekmekci, F.S, Beard, C.M, O'Brien, P.C, & Kurland, L.T. (1994). Incidence and prevalence of Huntington's disease in Olmsted County, Minnesota (1950 through 1989). Archives of Neurology, 51, 696-698.
35. Koller, W.C. (1983). Edentulous orodyskinesia. Annals of Neurology, 13, 97-99.
36. Koller,W.C., Hristova, A., & Brin, M. (2000a). Pharmacologic treatment of essential tremor. Neurology, 54 (suppl 4), S30-S38.
37. Koller, W.C., Pahwa, R., Lyons, K.E., & Wilkinson, S.B. (2000b). Deep brain stimulation of the Vim nucleus of the thalamus for the treatment of tremor. Neurology, 55 (suppl 6), S29-S33.
38. Kramer, P.L., Mineta, M., Klein, C., Schilling K, de Leon, D., Farlow, M.R., Breakefield, X.O., Bressman, S.B., Dobyns, W.B., Ozelius, L.J, & Brashear. A. (1999). Rapid onset dystoniaparkinsonism: linkage to chromosome 19q13. Annals of Neurology, 46, 176-182.
39. Kurlan, R. (2003). Tourette's syndrome: are stimulants safe? Current Neurology and Neuroscience Reports, 3, 285-288.
40. Kwak, C.H., Hanna, P.A., Jankovic, J. (2000). Botulinum toxin in the treatment of tics. Archives of Neurology, 57, 1190-1193.
41. Langston, J.W., Forno, L.S., Tetrud, J., Reeves, A.G., Kaplan, J.A., & Karluk, D. (1999). Evidence of active nerve cell degeneration in the substantia nigra of human years after 1-methyl- 4-phenyl-1,2,3,6- tetrahydropyridine exposure. Annals of Neurology, 46, 598-605.
42. Lauciello, F., & Appelbaum, M. (1977). Prosthodontic implication of tardive dyskinesia. New York State Dentistry Journal, 43, 214-217.
43. Leksell,E.,& Edvardson, S. (2005). A case of Tourette syndrome presenting with oral self-injurious behavior. International Journal of Pediatric Dentistry, 15, 370-374.
44. Litvan, I., MacIntyre, A., Goetz, C.G., Wenning, G.K., Jellinger, K., Verny, M., Bartko, J.J., Jankovic, J., McKee, A., Brandel, J.P., Chaudhuri, K.R., Lai, E.C., D'Olhaberriaque, L., Pearce, R.K., & Agid, Y. (1998). Accuracy of the clinical diagnoses of Lewy body disease, Parkinson's disease and dementia with Lewy bodies: a clinicopathologic study. Archives of Neurology, 55, 969-978.
45. Litvan, I., Grimes, D.A., Lang, A.E., Jankovic, J., McKee, A., Verny, M., Jellinger, K., Chaundhuri, K.R., & Pearce, R.K. (1999). Clinical feature differentiating patient with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. Journal of Neurology, 246 ( suppl 2), II1-II5.
46. Lo, S.E., Gelb, M., & Frucht, S.J. (2007). Geste antogoniste in idiopathic lower cranial dystonia. Movement Disorders, 22, 1012-1017.
47. Lozano, A.M., & Abosch, A. (2004). Pallidal stimulation for dystonia. Advances in Neurology, 94, 301-308.
48. McKeith, I.G., Dickson, D.W., Lowe, J., Emre, M., O'Brien, J.T., Feldman, H., Cummings, J., Duda, J.E., Lippa, C., & Perry, E.K. (2005). Diagnosis and management of dementia with Lewy bodies: third report on the DLB consortium. Neurology, 65, 1863-1872.
49. Mink, J.W. (2001). Basal ganglia dysfunction in Tourette's syndrome: a new hypothesis. Pediatrics Neurology, 25, 190-198.
50. Nakayama, Y.,Washio, M., & Mori, M. (2004). Oral health conditions in patients with Parkinson's disease. Journal of Epidemiology, 14, 143-150.
51. Nutt, J.G., Muenter, M.D., Aronson, A., Kurland, L.T., & Melton, L.J. 3rd. (1988). Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Movement Disorders, 3, 188-194.
52. Olanow, C.W., Goetz, C.G., Kordower, J.H., Stoessl, A.J., Sosi, V., Brin, M.F., Shannon, K.M., Nauert, G.M., Perl, D.P., Godbold, J., & Freeman, T.B. (2003). A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Annals of Neurology, 54, 403-414.
53. Paisan-Ruiz, C., Lang, A.E., Kawarai, T., & Sato, C. (2005). LRRK2 gene in Parkinson disease: mutation analysis and case control association study. Neurology, 65, 696-700.
54. Polymeropoulos, M.H., Lavedan, C., & Leroy, E. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science, 276, 2045-2047.
55. Pradhan, S., Pander, N., Shashank, S., Gupta, R.K., & Mathur, A. (1999). Parkinsonism due to predominant involvement of substantia nigra in Japanese Encephalitis. Neurology, 53, 1781-1786.
56. Rajput, A.H. (1994). Clinical features and natural history of Parkinson's disease (Special consideration of aging). In: D.B. Calne (Eds.), Neurodegenerative diseases (pp. 555-571). Philadelphia: WB Saunders.
57. Riley, D., & Lang, A.E. (1989). Pain in Gilles de la Tourette's syndrome and related tic disorders. Canadian Journal of Neurological Science, 16, 439-441.
58. Rodriquez-Oroz, M.C., Obeso, J.A., Lang, A.E., Houeto, J.L. Pollak, P., Rehncrona, S., Kulisevsky, J., Albanese, A., Volkmann, J., Hariz, M.I., Quinn, N.P., Speelman, J.D., Guridi, J., Zamarbide, I., Gironell, A., Molet, J., Pascual-Sedno, B., Pidoux, B., Bonnet, A.M., Ajid, Y., Xie, J., Benabid, A.L., Lozano, A.M., Saint-Cyr, J., Romito, L., Contarino, M.F., Scerrati, M., Fraix, V., & Van Blercom, N. (2005). Bilateral deep brain stimulation in Parkinson's disease: a multicentral study with 4 years follow - up. Brain, 128, 2240-2249.
59. Saito, Y., Matsuoka, Y., Takahashi, A., & Ohno, Y. (1994). Survival of patients with multiple system atrophy. Internal Medicine, 33, 321-325.
60. Sankhla, C., Lai, E.C., & Jankovic, J. (1998). Peripherally induced oromandibular dystonia. Journal of Neurology, Neurosurgery and Psychiatry, 65, 722-728.
61. Santacruz, P., Uttl, B., Livan, I., & Grafman, J. (1998). Progressive supranuclear palsy: A survery of the disease course. Neurology, 50, 1637-1647.
62. Schoenberg, B.S., Anderson, D.W., & Haerer, A.F. (1985). Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi. Neurology, 35, 841-845.
63. Schrag, A., Ben-Shlomo, Y., & Quinn, N.P. (1999). Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross - sectional study. Lancet, 354, 1771-1775.
64. Schrag, A., Bhatia, K.P, Quinn, N.P, &Marsden, C.D. (1999). Atypical and typical cranial dystonia following dental procedures. Movement Disorders, 14, 492-496.
65. Segawa, M., Hosaka, A., Miyagawa, F., Nomura, Y., & Imai H. (1976). Hereditary progressive dystonia with marked diurnal fluctuation. Advances in Neurology, 14, 215-233.
66. Sejvar, J.J., Haddad, M.B., Tierney, B.C., Campbell, G.L., Marfin, A.A., Van Gerpen, J.A., Fleischauer, A., Leiss, A.A., Stokic, D.S., & Petersen, L.R (2003). Neurologic manifestations and outcome of West Nile Virus infection. Journal of American Medical Association, 290, 511-515.
67. Shahed, J., Poysky, J., Kenney, C., Simpson, R., & Jankovic, J. (2007). GPi deep brain stimulation for Tourette syndrome improves tics and psychiatric comorbilities. Neurology, 68, 159-160.
68. Singer, C. (1997). Tourette syndrome. Coprolalia and other coprophenomena. Neurological Clinics, 15, 299-308.
69. Sutcher, H., Soderstrom, J., Perry, R., & Das, A. (1998). Tardive dyskinesia: dental prosthetic therapy. Panminerva medica, 40, 154-156.
70. Sutcher, H.D., Underwood, R.B., Beatty, R.A., & Sugar O. (1971). Orofacial dyskinesia - a dental dimension. Journal of American Medical Association, 216, 1459-1463.
71. Tanner, C.M. (1992). Occupational and environmental causes of parkinsonism. Occupational Medicine, 7, 503-513.
72. Uc, E.Y., Rizzo, M., Anderson, S.W., & Qian, S. (2005). Visual dysfunction in Parkinson disease without dementia. Neurology, 65, 1907-1913.
73. Volkmann, J., Allert, N., Vodes, J., Weiss, P.H., Freund, H.J., & Sturm, V. (2001). Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology, 57, 1354-1358.
74. Waddy, H.M., Fletcher, N.A, Harding, A.E., Marsden, C.D. (1991). A genetic study of idiopathic dystonias. Annals of Neurology, 29, 320-324.
75. Woody, R.C., & Eisenhauer, G. (1986). Tooth extraction as a form of self- mutilation in Tourette's disorder. South Medical Journal, 79, 1466.
76. Yoshikawa, F., Takagi, T., Fukayama, H., Miwa, Z., & Umino, M. (2002). Intravenous sedation and general anesthesia for a patient with Gilles de la Tourette's syndrome undergoing dental treatment. Acta Anasthesiologica Scandinavia, 46, 1279-1280.
77. Zanettini, R., Antonini, A., Gatto, G., Gentile, R., Tesei, S., & Pezzoli, G. (2007). Valvular heart disease and the use of dopamine agonists for Parkinson's disease. New England Journal of Medicine, 356, 39-46.